Axon Enterprise, Inc $AXON Shares Purchased by Oak Ridge Investments LLC

Oak Ridge Investments LLC grew its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 1.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 16,283 shares of the biotechnology company’s stock after acquiring an additional 166 shares during the quarter. Axon Enterprise comprises approximately 1.0% of Oak Ridge Investments LLC’s investment portfolio, making the stock its 21st largest holding. Oak Ridge Investments LLC’s holdings in Axon Enterprise were worth $13,481,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Hemington Wealth Management increased its holdings in shares of Axon Enterprise by 70.8% during the second quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock valued at $33,000 after acquiring an additional 17 shares in the last quarter. TCTC Holdings LLC increased its holdings in shares of Axon Enterprise by 75.0% during the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock valued at $29,000 after acquiring an additional 24 shares in the last quarter. Bartlett & CO. Wealth Management LLC increased its holdings in shares of Axon Enterprise by 132.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock valued at $31,000 after acquiring an additional 33 shares in the last quarter. Catalyst Capital Advisors LLC acquired a new position in shares of Axon Enterprise during the first quarter valued at about $32,000. Finally, Banque Transatlantique SA acquired a new position in shares of Axon Enterprise during the first quarter valued at about $31,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Trading Down 4.2%

Axon Enterprise stock opened at $703.03 on Friday. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. Axon Enterprise, Inc has a 12 month low of $422.38 and a 12 month high of $885.91. The stock’s 50 day simple moving average is $755.57 and its two-hundred day simple moving average is $713.70. The firm has a market cap of $55.19 billion, a PE ratio of 173.59, a P/E/G ratio of 27.30 and a beta of 1.41.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, topping the consensus estimate of $1.54 by $0.58. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The business had revenue of $668.54 million for the quarter, compared to analyst estimates of $641.77 million. During the same quarter in the prior year, the firm posted $1.20 EPS. The business’s quarterly revenue was up 32.6% compared to the same quarter last year. Axon Enterprise has set its FY 2025 guidance at EPS. Analysts anticipate that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on AXON. Morgan Stanley set a $885.00 price objective on shares of Axon Enterprise and gave the company an “overweight” rating in a report on Friday, July 11th. Zacks Research lowered Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 2nd. Bank of America upped their target price on Axon Enterprise from $895.00 to $1,000.00 and gave the company a “buy” rating in a research report on Wednesday, August 6th. Weiss Ratings reiterated a “hold (c)” rating on shares of Axon Enterprise in a research report on Wednesday. Finally, UBS Group reiterated a “neutral” rating and issued a $840.00 target price (up previously from $820.00) on shares of Axon Enterprise in a research report on Tuesday, August 5th. Fourteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $841.64.

Insiders Place Their Bets

In other Axon Enterprise news, President Joshua Isner sold 15,919 shares of the company’s stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $746.26, for a total value of $11,879,712.94. Following the sale, the president owned 238,379 shares in the company, valued at approximately $177,892,712.54. This represents a 6.26% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CFO Brittany Bagley sold 5,000 shares of the company’s stock in a transaction that occurred on Monday, September 29th. The stock was sold at an average price of $713.88, for a total value of $3,569,400.00. Following the completion of the sale, the chief financial officer owned 93,592 shares in the company, valued at approximately $66,813,456.96. This represents a 5.07% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 59,932 shares of company stock worth $45,115,616. Corporate insiders own 4.40% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.